3[1]Macdougall IC,Cooper AC.Erythropoietin resistance:the role of inflammation and pro-inflammatory cytokines[J].Nephrol Dial Transplant,2002,17(Suppl 11):39-43.
4[2]Cooper AC,Breen CP,Vyas B,et al.Poor response to recombinant erythropoietin is associated with loss of T-lymphocyte CD28 expression and altered interleukin-10 production[J].Nephrol Dial Transplant,2003,18:133-140.
5[3]Deenitchina SS,Ando T,Okuda S,et al.Cellular immunity in hemodialysis patients:a quantitative analysis of immune cell subsets by flow cytometry[J].Am J Nephrol,1995,15 (1):57-65.
6[5]Deenitchina SS,Ando T,Okuda S,et al.Cellular immunity in hemodialysis patients:a quantitative analysis of immune cell subsets by flow cytomytry[J].Am J Nephrol,1995,15 (1):57.
7[6]Eschbach J,DeOreo P,Adamson J,et al.RHuEPO clinical practice guidelines for the treatment of anemia of chronic renal failure[J].Am J Kidney Dis,1997,30(Suppl3):S192-S240.
8Schwerter HA, Jackson WG, Tolan G. Association of low serum conecentration of bilirubin with increased risk of coronary artery disease. Clin Chem, 1994,40(16) : 18 - 23.
9Cilan H, Sipahioglu MH, Oguzhan N, et al. Association between depression, nutritional status, and inflammatory markers in perito- neal dialysis patients. Ren Fail ,2013,35 ( 1 ) : 17 - 22.
10Cilan H, Sipahioglu MH, Oguzhan N, et al. Association between depression, nutritional status, and inflammatory markers in perito- neal dialysis patients. Ren Fail ,2013 ;35 ( 1 ) : 17 - 22.
